VEGF and its receptors (flt-1 and KDR/flk-1) as prognostic indicators in endometrial carcinoma

Tumor Biology

Volumn 26, Issue 2, 2005, Pages 81-87

  Talvensaari Mattila, Anne ^a   Soini, Ylermi ^a   Santala, Markku ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b Box 24   (Finland)

Author keywords

Endometrial carcinoma; flt 1; KDR flk 1; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ACANTHOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE MARKER; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING; SURVIVAL RATE; TISSUE SECTION;

EID: 20444496482     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085589     Document Type: Article

References (25)

1. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364.
2. Ferrara N: Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999;56:794-814.
3. Giatromanolaki A, Stathopoulos GP, Tsiobanou E, Papadimitriou C, Georgoulias V, Gatter KC, Harris AL, Koukourakis MI: Combined role of tumor angiogenesis, bcl-2 and p53 expression in the prognosis of patients with colorectal carcinoma. Cancer 1999;86:1421-1430.
4. Salven P, Ruotsalainen T, Mattson K, Joensuu H: High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer. Int J Cancer 1998;79:144-146.
5. Koukourakis MI, Giatromanolaki A, Fountzilas G, Sivridis E, Gatter KC, Harris AL: Angiogenesis, thymidine phosphorylase and resistance of head and neck cancer to cytotoxic and radiation therapy. Clin Cancer Res 2000;6: 381-389.
6. Chen CA, Cheng WF, Lee CN, Chen TM, Kung CCS, Hsieh FJ, Hsieh CY: Serum vascular endothelial growth factor in epithelial ovarian neoplasms: Correlation with patient survival. Gynecol Oncol 1999;74:235-240.
7. Tjalma W, Van Marck E, Weyler J, Dirix L, Van Daele A, Goovaerts G, Albertyn G, Van Dam P: Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer 1998;78:170-174.
8. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL: Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-1124.
9. Sivridis E, Giatromanolaki A, Anastasiadis P, Georgiou L, Gatter KC, Harris AL, Bicknell R, Koukourakis MI; Tumor and Angiogenesis Group: Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas. J Pathol 2002;196:416-422.
10. Chen CA, Cheng WF, Lee CN, Wei LH, Chu JS, Hsieh FJ, Hsieh CY: Cytosol vascular endothelial growth factor in endometrial carcinoma: Correlation with disease-free survival. Gynecol Oncol 2001;80:207-212.
11. Fine BA, Valente PT, Feinstein GI, Dey T: VEGF, flt-1 and KDR/flk-1 as prognostic indicators in endometrial carcinoma. Gynecol Oncol 2000;76:33-39.
12. Fujisawa T, Watanabe J, Akaboshi M, Ohno E, Kuramoto H: Immunohistochemical study on VEGF expression in endometrial carcinoma - comparison with p53 expression, angiogenesis, and tumor histologic grade. J Cancer Res Clin Oncol 2001;127:668-674.
13. Yokoyama Y, Sato S, Futagami M, Fukushi Y, Sakamoto T, Umemoto M, Saito Y: Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma. Gynecol Oncol 2000;77:413-418.
14. Shweiki D, Neeman M, Itin A, Keshet E: Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multiple spheroids: Implications for tumor angiogenesis. Proc Natl Acad Sci USA 1995;92:768-772.
15. Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Petersson RF, Alitalo K, Erikson U: Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996;93:2576-2581.
16. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinase. EMBO J 1996;15:290-298.
17. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 1998;95:548-553.
18. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
19. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
20. Pajusola K, Aprelikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R, Alitalo K: FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 1992;52:5738-5743.
21. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VWM, Fang G-H, Dumont D, Beitman M, Alitalo K: Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995;92:3566-3570.
22. Mueller M, Vigne J, Minchenko D, Lebovic D, Leitman D, Taylor R: Regulation of vascular endothelial growth (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci USA 2000;97:10972-10977.
23. Folkman J: Tumor angiogenesis. Adv Cancer Res 1985;43:175-203.
24. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T: Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells. Cancer Lett 1999;141: 63-71.
25. Landgren E, Schiller P, Cao Y, Claesson-Weish L: Placental growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt-1. Oncogene 1998;16:359-367.